» Articles » PMID: 34948441

In Situ Cell Signalling of the Hippo-YAP/TAZ Pathway in Reaction to Complex Dynamic Loading in an Intervertebral Disc Organ Culture

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Dec 24
PMID 34948441
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, a dysregulation of the Hippo-YAP/TAZ pathway has been correlated with intervertebral disc (IVD) degeneration (IDD), as it plays a key role in cell survival, tissue regeneration, and mechanical stress. We aimed to investigate the influence of different mechanical loading regimes, i.e., under compression and torsion, on the induction and progression of IDD and its association with the Hippo-YAP/TAZ pathway. Therefore, bovine IVDs were assigned to one of four different static or complex dynamic loading regimes: (i) static, (ii) "low-stress", (iii) "intermediate-stress", and (iv) "high-stress" regime using a bioreactor. After one week of loading, a significant loss of relative IVD height was observed in the intermediate- and high-stress regimes. Furthermore, the high-stress regime showed a significantly lower cell viability and a significant decrease in glycosaminoglycan content in the tissue. Finally, the mechanosensitive gene was significantly downregulated overall, and the Hippo-pathway gene was significantly upregulated in the high-stress regime. This study demonstrates that excessive torsion combined with compression leads to key features of IDD. However, the results indicated no clear correlation between the degree of IDD and a subsequent inactivation of the Hippo-YAP/TAZ pathway as a means of regenerating the IVD.

Citing Articles

Ex Vivo and In Vitro Proteomic Approach to Elucidate the Relevance of IL-4 and IL-10 in Intervertebral Disc Pathophysiology.

Bermudez-Lekerika P, Tseranidou S, Kanelis E, Nuesch A, Crump K, Alexopoulos L JOR Spine. 2025; 8(1):e70048.

PMID: 39931581 PMC: 11808320. DOI: 10.1002/jsp2.70048.


Role of YAP/TAZ in bone diseases: A transductor from mechanics to biology.

Chen X, Ji X, Lao Z, Pan B, Qian Y, Yang W J Orthop Translat. 2025; 51:13-23.

PMID: 39902099 PMC: 11787699. DOI: 10.1016/j.jot.2024.12.003.


The Role of the Bone Morphogenetic Protein Antagonist Noggin in Nucleus Pulposus Intervertebral Disc Cells.

Chen S, Bigdon S, Riether C, Ma X, Niu X, Hackel S Int J Mol Sci. 2024; 25(21).

PMID: 39519354 PMC: 11546912. DOI: 10.3390/ijms252111803.


Repetitive strikes loading organ culture model to investigate the biological and biomechanical responses of the intervertebral disc.

Zhou J, Wang J, Li J, Zhu Z, He Z, Li J JOR Spine. 2024; 7(1):e1314.

PMID: 38249719 PMC: 10797252. DOI: 10.1002/jsp2.1314.


Morroniside attenuates nucleus pulposus cell senescence to alleviate intervertebral disc degeneration inhibiting ROS-Hippo-p53 pathway.

Zhou C, Yao S, Fu F, Bian Y, Zhang Z, Zhang H Front Pharmacol. 2022; 13:942435.

PMID: 36188539 PMC: 9524229. DOI: 10.3389/fphar.2022.942435.


References
1.
Wong M, Siegrist M, Cao X . Cyclic compression of articular cartilage explants is associated with progressive consolidation and altered expression pattern of extracellular matrix proteins. Matrix Biol. 1999; 18(4):391-9. DOI: 10.1016/s0945-053x(99)00029-3. View

2.
Patel K, Sandy J, Akeda K, Miyamoto K, Chujo T, An H . Aggrecanases and aggrecanase-generated fragments in the human intervertebral disc at early and advanced stages of disc degeneration. Spine (Phila Pa 1976). 2007; 32(23):2596-603. DOI: 10.1097/BRS.0b013e318158cb85. View

3.
Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N . A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell. 2013; 154(5):1047-1059. DOI: 10.1016/j.cell.2013.07.042. View

4.
Oichi T, Taniguchi Y, Oshima Y, Tanaka S, Saito T . Pathomechanism of intervertebral disc degeneration. JOR Spine. 2020; 3(1):e1076. PMC: 7084053. DOI: 10.1002/jsp2.1076. View

5.
Heidary Arash E, Shiban A, Song S, Attisano L . MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells. EMBO Rep. 2017; 18(3):420-436. PMC: 5331264. DOI: 10.15252/embr.201642455. View